UNSPSC 51392412: Dopamine hydrochloride

This classification denotes a dopamine agent with the molecular formula C8H11NO2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7L3E358N9L, chemically known as 3,4-dihydroxyphenylethylamine but more generally known as dopamine hydrochloride, which bears US NIH Compound Identifier 681. European Medicines Agency schedules Dopamine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01818MIG.

Most nations, for tariff and trade purposes, schedule dopamine hydrochloride under HS 29222900 and SITC 51462. As of Q4 2014, DOPAMINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Dopamine hydrochloride bears US NLM identifiers UMLS ID C0282151 and NCI Concept Code C455. SMILES: C1CC(C(CC1CCN)O)O.CL.

UNSPSC 51392412 Dopamine hydrochloride is a Commodity code that shows minimal recent state and local activity directly aligned with its nominal scope. The single recent opportunity in the dataset—Seminole County, Florida's IFB 60459723LAS—is tagged to this code but solicits naloxone and safe drug deactivation systems, not dopamine hydrochloride. The mismatch between the code's pharmaceutical specificity and the actual procurement being conducted suggests either a tagging error in the source or that state and local purchasing offices are using this code to encompass a broader family of emergency medical and harm-reduction pharmaceuticals and systems.

Seminole County issued the naloxone and drug deactivation systems bid as an IFB with a response deadline of July 26, 2023, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually on a two-year term with one-year renewal option. Delivery is quarterly to the Seminole County Community Health Building in Sanford, with all shipping and handling costs included in vendor pricing. The procurement includes standard compliance requirements—E-Verify, drug-free workplace certification, workers' compensation and commercial general liability insurance—and potential FEMA funding with attendant federal environmental compliance obligations. The narrow recent-opportunity set under this code does not support a reliable characterization of geographic spread or issuing-body patterns in dopamine hydrochloride procurement at the state and local level.